General Catalyst

General Catalyst is a venture capital firm established in 2000 and based in San Francisco, California. The firm specializes in early-stage and growth equity investments across various sectors, including consumer, enterprise, fintech, cryptocurrency, and health assurance. By fostering an environment conducive to growth, General Catalyst aims to accelerate the development of innovative ideas and companies. The firm provides mentorship and connects clients with experienced professionals to enhance their potential for success. As a Registered Investment Adviser, General Catalyst has managed a total of eight venture capital funds, accumulating approximately $3.75 billion in capital commitments.

Adrian Abeijon

Investor

Allen CPA, Mark J.

CFO

Neeraj Arora

Managing Director, Investment Team

Juliet Bailin

Principal

Bhargava, Marc

Managing Director

Larry Bohn

Managing Director

Teresa Carlson

President, General Catalyst Institute

Kenneth Chenault

Chairman and Managing Director

Clark, Quentin J.

Managing Director

Mark Crane

Partner

Joel Cutler JD

Co-Founder and Managing Director

Chris Davis

Partner

Kyle Doherty

Managing Director

David Fialkow

Co-Founder and Managing Director

Diana Hong

Investor

Mina Hsiang

Associate

Nmachi Jidenma

Partner

Christopher Kauffman

Principal

Zak Kukoff

Principal

Paul Kwan

Managing Director

Karanveer Mohan

Managing Director, Investment Team

Priya Mohan

Partner, Investment Team

Deep Nishar

Managing Director

Dipchand Nishar

Managing Director

Reva Nohria

Investor

Trevor Oelschig

Managing Director

Tyler Olkowski

Investor

David Orfao

Managing Director and Co-Founder

Pranay Orugunta

Healthcare Investor

Mo Punjwani

Associate, Investments

Candace Richardson

Principal

Rimpel, Max

Partner

Sam Rosen

Growth Investor

Pranav Singhvi

Partner

Bill Skarinka

Associate

Hemant Taneja

CEO and Managing Director

Alexander Tran

Managing Director

Catherine Tu

Partner, Investment Team

Adam Valkin

Managing Director

Elena Viboch

Partner

Andrea Wang

Principal, Early Stage Investment

Nathaniel Levy-Westhead

Partner, Investment Team

Peter Boyce II

Partner

Deep Nishar

Managing Director and Member of the Management Committee

Roy Mabrey

Partner, Investment Team

Past deals in Healthcare

RISA Labs

Seed Round in 2025
RISA Labs utilizes Multi-Agent Systems to reimagine healthcare, enhancing efficiency and elevating patient care. The company's MAS interface sparks innovation in healthcare, aiming to make healthcare administration more intelligent, responsive, and centered around patients.

Thatch

Series B in 2025
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.

Stance Health

Pre Seed Round in 2025
Stance Health, a healthtech startup focusing on musculoskeletal (MSK) care.

Sohar Health

Seed Round in 2025
Sohar Health is a platform focused on enhancing the operations of behavioral health companies through a cloud-based eligibility verification and utilization reporting system. It provides an API-driven solution that facilitates eligibility verification and employs AI-powered medical coding to streamline manual workflows. The platform includes features designed to automate processes, manage eligibility files securely, and offer utilization analytics and reporting. This comprehensive approach enables digital health providers to scale their operations efficiently and increase revenue.

Taxo

Seed Round in 2025
Taxo automates healthcare administration using proprietary AI models

Eikon Therapeutics

Series D in 2025
Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.

Delve

Seed Round in 2025
Delve is a company that focuses on simplifying the process of achieving HIPAA compliance for its clients. It has developed a tracking platform that assists organizations in monitoring their compliance journey. The platform includes features such as work deployment, paperwork automation, and compliance monitoring. By offering continuous integration and continuous deployment (CI/CD) pipelines, Delve enables clients to efficiently manage infrastructure updates directly from their code repositories. This approach helps organizations streamline their documentation processes, making it easier to meet regulatory requirements.

Neko Health

Series B in 2025
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.

Hippocratic AI

Series B in 2025
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Orange Health Labs

Venture Round in 2024
Orange Health Labs is a health tech startup focused on providing diagnostic lab services that enable doctors to deliver care remotely. The company aims to enhance patient convenience by allowing individuals to receive home sample collection and access to test results without the need for clinic visits. By adopting a patient-centric approach, Orange Health helps reduce wait times for test results and facilitates efficient testing for blood tests, checkups, and pathology services. This innovative model supports the vision of making healthcare more accessible and seamless for consumers in their homes.

Soda Health

Series B in 2024
Soda Health is a healthcare technology company founded in 2021 and based in Chicago, Illinois. The company focuses on addressing health inequities by leveraging social determinants of health. It offers a technology platform designed to assist individuals in identifying, accessing, and funding the resources necessary for a healthy life. By providing a system for administering and reimbursing personalized benefits, Soda Health enables customers to effectively bridge the gap between medical claims and retail payments, ultimately promoting better health outcomes.

OASYS NOW

Seed Round in 2024
OASYS NOW is a technology platform focused on improving the treatment journey for chronic patients by efficiently connecting them with relevant clinical trials tailored to their unique health data. The platform utilizes advanced algorithms to match patients with suitable global clinical trials, thereby increasing their opportunities for personalized treatment options. OASYS NOW emphasizes patient privacy through a privacy-by-design approach while harnessing extensive medical data to enhance health outcomes. Additionally, the company provides secure data-sharing solutions and ethical data processing systems aimed at organizations in the health and genomics sectors, ensuring a robust and secure infrastructure for sensitive health information.

Pharos

Seed Round in 2024
Pharos is a Hospitals and Health Care tech that helps with quality reporting without any manual chart review.

Alpha9 Theranostics

Series C in 2024
Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.

Primus

Seed Round in 2024
Primus helps elderly people slow the aging process by eliminating loneliness and achieving 'Zero Falls'. We ensure that we are proactive rather than reactive by conducting a series of examinations prior to onboarding elders so that they can be monitored by our in-house medical staff under a personalized care plan.

Astrix Health

Pre Seed Round in 2024
Astrix builds AI purchasing agents for healthcare providers. Astrix helps providers secure better deals on recurring medical supplies, equipment, and pharmacy orders by using AI to find the best offers from reputable vendors. Powered by generative AI, Astrix aggregates and normalizes data from millions of sources, delivering actionable pricing insights for buyers and sellers alike. Our team brings expertise in building AI systems from Palantir, Oxford, Duke Health, and MedStar Health. Backed by Y Combinator, Astrix operates globally from San Francisco, NYC, and London.

Taxo

Seed Round in 2024
Taxo automates healthcare administration using proprietary AI models

Thatch

Series A in 2024
Thatch is a health benefits platform designed to assist businesses in managing employee healthcare effectively. It features an AI-driven service known as ThatchBot, which provides continuous support to employees for healthcare inquiries and expense management. The platform allows companies to create customized healthcare budgets that cater to individual employee needs. By offering a unified interface for healthcare spending and saving, Thatch enhances the delivery of personalized health and wellness benefits, enabling employees to navigate their healthcare options with greater ease and efficiency.

Doccla

Series B in 2024
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Clarium

Venture Round in 2024
Clarium is a company focused on enhancing healthcare operations through its artificial intelligence-based platform. This platform is designed to automate various business processes within healthcare settings by collecting and analyzing data from existing systems. It filters out noise, errors, and outliers to predict demand accurately, allowing healthcare providers to manage staffing and supplies more effectively. By enabling hospitals and healthcare centers to avoid shortages and stockouts, Clarium helps to reduce supplier lead times and identify alternative products, ultimately improving operational efficiency and patient care.

MD Ally

Series A in 2024
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Adonis

Series B in 2024
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges affecting revenue cycle management (RCM). Healthcare providers frequently fail to collect over 15% of their entitled revenue due to systemic issues within traditional RCM processes. Adonis utilizes data science and artificial intelligence to identify vulnerabilities and streamline operations, enhancing claim accuracy and detecting underpayments. By automating routine tasks, the platform minimizes administrative burdens, allowing medical providers to concentrate on patient care while optimizing financial outcomes. Through these innovative solutions, Adonis aims to improve revenue collection for healthcare organizations.

Better Health

Series A in 2024
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Triomics

Series A in 2024
Triomics is a generative AI-powered platform focused on enhancing the efficiency of clinical trials, particularly in the field of oncology. The company aims to accelerate trial enrollment and improve healthcare operations by addressing operational inefficiencies in data collection and patient recruitment. Leveraging its advanced AI technology, which is trained to understand health records and medical terminology, Triomics facilitates a more streamlined approach to clinical research. Its platform supports pharmaceutical companies and contract research organizations in conducting rapid and cost-effective trials, ultimately advancing oncology research and care.

Transcarent

Series D in 2024
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

InStride Health

Series B in 2024
InStride Health provides evidence-based OCD and anxiety treatment to keep kids and teenagers engaged along the way.

Hippocratic AI

Series A in 2024
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Empathy

Series B in 2024
Empathy is a platform designed to assist families in navigating the complexities of loss. By integrating technology with human support, Empathy offers a digital companion application that empowers bereaved families. The application serves as a comprehensive support system, guiding users through the emotional, financial, legal, and logistical challenges that arise after the death of a loved one. Through its innovative approach, Empathy aims to alleviate some of the burdens faced by families during difficult times.

Chamber Cardio

Seed Round in 2024
Chamber Cardio is a healthcare platform focused on enhancing cardiovascular health services by facilitating the transition of cardiologists to value-based care. The company provides a range of services, including panel management with real-time updates, financial metrics, and clinical data consolidated into a user-friendly dashboard. Additionally, it offers software support to manage complex patient cases and engages in value-based contracting. This comprehensive approach aims to improve treatment accessibility for patients and streamline operations within the healthcare sector.

Overjet

Series C in 2024
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.

Finni Health

Series A in 2024
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.

Fabric

Series A in 2024
Fabric is a health tech company that enables healthcare providers to deliver faster, higher quality, and more accessible care while reducing costs via consumer-grade patient experiences that automate workflows for staff.

Genial Care

Venture Round in 2024
Genial Care is a company based in São Paulo, Brazil, dedicated to providing specialized services for children with autism and developmental difficulties. Founded in 2020, it operates a network of both physical and digital clinics that offer real-time monitoring of the child's progress. In addition to direct care, Genial Care provides training programs for parents and therapists, ensuring personalized attention and support tailored to the needs of each child. The company's holistic approach aims to transform the lives of children with autism and their families, helping them to achieve their full potential.

Phare Health

Seed Round in 2023
Phare Health transforms the back office of healthcare, making it more efficient, accurate, and resillient.

Evvy

Series A in 2023
Evvy is a company focused on improving female health by offering at-home vaginal microbiome tests. These tests utilize metagenomic sequencing to analyze symptoms and identify risks associated with important health issues. By providing personalized reports, Evvy aims to empower women with insights about their bodies, thereby addressing the gender health gap and enhancing overall health outcomes for women.

Cartwheel

Series A in 2023
Cartwheel is a provider of mental health support specifically designed for the school community, founded in 2022 and based in Cambridge, Massachusetts. The company addresses the growing mental health crisis among students by offering evidence-based services from licensed clinicians. Cartwheel partners with schools to facilitate rapid access to mental health assessments, therapy, and medication evaluations, aiming to empower school staff, alleviate family stress, and enhance overall student mental health outcomes. Its program is compliant with FERPA and HIPAA regulations, ensuring it meets the unique needs of educational institutions in the aftermath of the COVID-19 pandemic. By focusing on creating a supportive environment, Cartwheel helps schools become places where every student can thrive.

Georgiamune

Series A in 2023
Georgiamune is an immunotherapy company dedicated to advancing oncology treatments. The firm specializes in next-generation immunotherapeutic and homeostatic therapies aimed at addressing cancer and autoimmune diseases. By focusing on innovative approaches, Georgiamune seeks to enhance patient recovery from cancer, contributing to significant breakthroughs in the field of immunotherapy.

Neko Health

Series A in 2023
Neko Health is a Swedish health-tech company focused on enhancing healthcare through prevention and early detection of diseases. It has developed innovative medical scanning technology that enables comprehensive and non-invasive health data collection, making it accessible and affordable for the general public. By leveraging sensor technology and artificial intelligence, Neko Health aims to reduce the prevalence of common diseases and their associated healthcare costs. The company provides doctors and clinicians with tools for flexible and cost-effective examinations, ultimately aiming to improve the quality of healthcare and promote proactive health management.

Berry Health

Pre Seed Round in 2023
Berry Health is a consumer health startup dedicated to improving lives by addressing under-served and stigmatized medical conditions. The company specializes in remote diagnosis and treatment for chronic health issues through online private medical consultations. Berry Health provides prescription medications and nationwide delivery, empowering patients to take control of their health. The services offered cover a wide range of conditions, including dermatology, mental health, sexual health, hair loss, and more, benefiting both men and women. By focusing on enhancing patient agency, Berry Health aims to promote better health outcomes, reduce inflammation and pain, optimize immunity, and improve brain health.

Adonis

Series A in 2023
Adonis is a healthcare revenue intelligence and automation platform that addresses operational challenges affecting revenue cycle management (RCM). Healthcare providers frequently fail to collect over 15% of their entitled revenue due to systemic issues within traditional RCM processes. Adonis utilizes data science and artificial intelligence to identify vulnerabilities and streamline operations, enhancing claim accuracy and detecting underpayments. By automating routine tasks, the platform minimizes administrative burdens, allowing medical providers to concentrate on patient care while optimizing financial outcomes. Through these innovative solutions, Adonis aims to improve revenue collection for healthcare organizations.

Hippocratic AI

Seed Round in 2023
Hippocratic AI focuses on developing safety-oriented large language models specifically designed for non-diagnostic, patient-facing applications in healthcare. Unlike conventional models that are often trained on diverse internet data, which may include unreliable information, Hippocratic AI emphasizes the acquisition of evidence-based healthcare content through lawful channels. The company aims to enhance healthcare accessibility and outcomes by creating a platform that facilitates safe artificial health general intelligence. This innovation seeks to empower patients to manage their health more effectively from home, thereby improving overall health outcomes with minimal inconvenience.

Memora Health

Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.

CTRL Therapeutics

Seed Round in 2023
CTRL Therapeutics is a biotechnology company based in Toronto, Canada, focused on the development of cell therapies and innovative diagnostic solutions. The company has created a microfluidic platform that enhances the detection of rare circulating tumor cells. This technology is integral to the development of a cancer liquid biopsy test, which aims to predict how patients will respond to targeted therapies. By enabling the evaluation of protein expression on tumor cells, CTRL Therapeutics seeks to provide valuable insights for doctors in tailoring treatment plans for cancer patients.

Finni Health

Seed Round in 2023
Finni enables passionate ABA providers to start and grow their own in-network practices. We empower providers to go independent in as little as 30 days and offer a complete full-stack solution to run their practice.

MD Ally

Seed Round in 2023
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Maribel Health

Series A in 2023
Maribel Health focuses on developing and operating advanced clinical care models that deliver healthcare services in home and community settings. The company aims to enhance the overall capacity of health systems and improve patient access by offering innovative home-based care solutions. In addition to its care models, Maribel Health provides assessment and planning services for home and community-based care, addressing the specific needs of local markets and healthcare organizations. Through these initiatives, the company seeks to facilitate better healthcare delivery and support the strategic goals of its partners.

Faro Health

Series A in 2023
Faro Health is a developer of a cloud-based medical platform aimed at addressing the complexities of clinical trials. The platform standardizes, automates, and streamlines various challenges associated with clinical studies. By utilizing an integrated clinical development environment, Faro Health simplifies the design and authoring of complex clinical protocols. This system leverages advanced digital protocols to provide intuitive insights during the authoring process, allowing clinical researchers to focus on critical decisions that enhance clinical value while minimizing administrative burdens.

Genial Care

Grant in 2023
Genial Care is a company based in São Paulo, Brazil, dedicated to providing specialized services for children with autism and developmental difficulties. Founded in 2020, it operates a network of both physical and digital clinics that offer real-time monitoring of the child's progress. In addition to direct care, Genial Care provides training programs for parents and therapists, ensuring personalized attention and support tailored to the needs of each child. The company's holistic approach aims to transform the lives of children with autism and their families, helping them to achieve their full potential.

Apiiro

Series B in 2022
Apiiro LLC is a code security startup based in New York that specializes in identifying security vulnerabilities within applications. The company has developed a Code Risk Platform that utilizes code behavior analysis to help organizations detect issues such as weak encryption and vulnerabilities to malware injection, as well as to ensure compliance with regulatory standards. By providing security and development teams with comprehensive visibility and actionable insights, Apiiro enables them to proactively address risks before deployment. The platform is particularly valuable to large enterprises in sectors such as gaming, healthcare, software development, and banking, allowing them to accelerate their delivery processes while effectively managing product risk. Founded in 2019, Apiiro aims to enhance the security of the software supply chain through its innovative approach to risk remediation.

Doccla

Series A in 2022
Doccla is a provider of virtual ward services that focuses on shifting patient care from hospitals to home settings. The company partners with care organizations to facilitate early patient discharge and reduce hospital readmissions through remote monitoring using advanced medical devices. By onboarding patients at home with the necessary monitoring equipment, Doccla employs a mobile team of healthcare professionals, including nurses and doctors, to oversee patient care. This approach not only ensures that patients receive timely and effective treatment but also aims to enhance care quality while lowering associated costs. Originally developed as part of a research initiative for the NHS, Doccla's innovative service has been successfully implemented in collaboration with Northampton General Hospital.

Redesign Health

Series C in 2022
Redesign Health is a company founded in 2018 that focuses on driving innovation in the healthcare sector. It develops technologies, tools, and insights designed to lower barriers to change within the industry. Redesign Health collaborates with exceptional founders to create and support over two dozen companies that have collectively impacted more than ten million lives across various healthcare domains, including cancer care, teleradiology, COVID-19 testing, and metabolic health. By fostering the growth of diverse healthcare solutions, Redesign Health aims to enhance the overall efficiency and effectiveness of healthcare delivery.

Certify

Series A in 2022
CertifyOS is a data intelligence platform focused on streamlining provider data management within the U.S. healthcare system. It provides an API-first and user interface agnostic solution that automates the entire provider network management lifecycle, including licensing, credentialing, and health plan enrollment. By integrating with numerous primary sources, CertifyOS offers near real-time verification and monitoring, facilitating efficient management of provider networks for insurance companies and virtual care providers. The platform aims to simplify and enhance the scalability of provider networking, positioning itself as a comprehensive resource for these critical operational needs.

Plume Clinic

Series B in 2022
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.

August Health

Series A in 2022
August Health is a high-growth company that builds technology to transform the quality of care for older adults residing in senior living communities. Together they've co-founded multiple successful companies, managed large engineering and product teams, shipped features used by hundreds of millions of users, and led clinical teams supporting thousands of patients.

Flexpa

Seed Round in 2022
Flexpa allows digital health apps to connect to new patient access APIs. Flexpa develops an API to integrate claims histories into any digital health or fintech app. The company was founded in 2021 and is located in San Francisco, California.

Sesame

Series B in 2022
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

CHARM Therapeutics

Series A in 2022
CHARM Therapeutics is focused on developing innovative medicines using advanced 3D deep learning and drug discovery technologies. The company's platform aims to address undruggable disease targets, providing healthcare professionals with effective treatment options for challenging medical conditions. By leveraging cutting-edge technology, CHARM Therapeutics seeks to create transformative therapies that have the potential to significantly improve patient outcomes.

Orange Health Labs

Series B in 2022
Orange Health Labs is a health tech startup focused on providing diagnostic lab services that enable doctors to deliver care remotely. The company aims to enhance patient convenience by allowing individuals to receive home sample collection and access to test results without the need for clinic visits. By adopting a patient-centric approach, Orange Health helps reduce wait times for test results and facilitates efficient testing for blood tests, checkups, and pathology services. This innovative model supports the vision of making healthcare more accessible and seamless for consumers in their homes.

Mirvie

Series B in 2022
Mirvie is a biotech company focused on developing non-invasive tests aimed at improving maternal-fetal health. Founded in 2018 and based in South San Francisco, California, Mirvie offers a medical diagnostic platform that provides actionable insights for mothers and families throughout their pregnancy journey. The company's innovative predictive tests help medical practitioners identify at-risk pregnancies, allowing for timely interventions and enhanced management of pregnancy-related concerns. By prioritizing safety and health, Mirvie seeks to empower families with the information necessary for better pregnancy outcomes.

MD Ally

Seed Round in 2022
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Alinea Health

Venture Round in 2022
Alinea Health is a health-tech startup that provides solutions for corporate health. It utilizes large amounts of data and proprietary algorithms to assist the client company's beneficiaries in navigating their health plans, providing personalized and unbiased guidance, recommendations from the most effective doctors in the accredited network, and conveniences such as scheduling consultations and exams. In addition to continuous monitoring, its doctors use the Lifestyle Medicine methodology to promote a healthy lifestyle and lower the risk of developing chronic diseases.

Avant-garde Health

Series A in 2022
Avant-garde Health, Inc. is a healthcare solutions company based in Allston, Massachusetts, founded in 2014. It specializes in developing a web-based analytics platform that assists hospitals and healthcare providers in analyzing and comparing their costs and outcomes in care delivery. The platform measures the costs of various care processes and evaluates treatment-specific data, enabling providers to learn from peer institutions and enhance their results. Avant-garde Health partners with leading healthcare providers committed to improving the value of care, offering actionable insights that facilitate better clinical decision-making and promote value-based payment models. The company was inspired by research on value-based healthcare delivery conducted at Harvard Business School.

Story Health

Series A in 2022
Story Health Corporation, founded in 2020 and based in Saratoga, California, develops advanced virtualized clinical care software tools aimed at aiding healthcare specialists, particularly neurologists and primary care physicians. The company offers a comprehensive healthcare technology platform that includes virtual patient programs, therapy management, and analytics designed to bridge the gap between clinical evidence and patient experiences. By utilizing data from high-frequency sources, Story Health empowers clinicians to better understand medical situations and make informed decisions regarding the physiological impacts of diseases and therapies. Through its innovative approach, Story Health enhances the ability of specialists to deliver effective patient care.

Equip Health

Series B in 2022
Equip is a virtual program helping families recover from eating disorders at home with comprehensive, gold-standard care created by experts in the field and people in recovery. Equip’s five-person care teams include dieticians, physicians, therapists, and mentors who deliver wrap-around support to provide families progress and lasting recovery. Kristina Saffran and Erin Parks co-founded the company in San Diego, California in 2019.

Ro

Venture Round in 2022
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Dewpoint Therapeutics

Series C in 2022
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.

Transcarent

Series C in 2022
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

Overjet

Series B in 2021
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.

Well

Series B in 2021
Well Dot, Inc. is a health technology company that has developed an artificial intelligence-based consumer health engagement platform and mobile application. Founded in 2019 and headquartered in Chapel Hill, North Carolina, with additional offices in Massachusetts, New York, and Minnesota, Well's platform uses clinical and consumer data to offer personalized health guidance and support. It analyzes individual health triggers to promote tailored, achievable steps for members to improve their health. The platform is designed to engage, educate, and empower users, providing easy-to-understand explanations and active assistance from health teams. By focusing on creating a meaningful and personalized health journey, Well aims to motivate individuals to adopt healthier habits and achieve better health outcomes.

Ophelia

Series B in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.

Cadence Solutions

Series B in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

Sword Health

Series D in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Variant Bio

Series B in 2021
Variant Bio Inc. is a biotechnology company based in Seattle, Washington, that focuses on developing therapeutics through the study of human genetic diversity. Founded in 2018, the company identifies individuals and populations that exhibit extreme traits of medical significance, utilizing advanced sequencing technologies and analytic methods to uncover the genes and pathways associated with these traits. By leveraging insights from genetic research, Variant Bio aims to discover new therapeutic targets for conditions such as neurodegenerative, autoimmune, and cardiometabolic diseases. The company's innovative approach combines statistical genetics and machine learning, enhancing the potential for genomic drug discovery to address unmet medical needs.

Color

Series E in 2021
Color is a healthcare technology company that provides a comprehensive platform for managing large-scale health initiatives, including population genomics and COVID-19 testing. The company focuses on delivering equitable and accessible healthcare programs tailored for businesses, schools, and public health departments. By centralizing essential healthcare capabilities, Color addresses logistical challenges and enhances the delivery of preventive care. Its offerings facilitate a range of services, from testing and screening to treatment and referrals, thereby supporting clinical teams in effectively managing public health across diverse populations. Through its innovative model, Color aims to improve health outcomes and create sustainable revenue streams while ensuring that quality healthcare is available to all.

Zerigo Health

Series B in 2021
Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. Clarify Medical indicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.

Better Health

Series A in 2021
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Sprinter Health

Series A in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Empathy

Series A in 2021
Empathy is a platform designed to assist families in navigating the complexities of loss. By integrating technology with human support, Empathy offers a digital companion application that empowers bereaved families. The application serves as a comprehensive support system, guiding users through the emotional, financial, legal, and logistical challenges that arise after the death of a loved one. Through its innovative approach, Empathy aims to alleviate some of the burdens faced by families during difficult times.

Orange Health Labs

Series A in 2021
Orange Health Labs is a health tech startup focused on providing diagnostic lab services that enable doctors to deliver care remotely. The company aims to enhance patient convenience by allowing individuals to receive home sample collection and access to test results without the need for clinic visits. By adopting a patient-centric approach, Orange Health helps reduce wait times for test results and facilitates efficient testing for blood tests, checkups, and pathology services. This innovative model supports the vision of making healthcare more accessible and seamless for consumers in their homes.

Overjet

Series A in 2021
Overjet, Inc. specializes in developing artificial intelligence (AI) software aimed at enhancing dental care. Founded by experts from MIT and Harvard, the company produces clinical optimization and utilization software that analyzes dental clinical data to assess practice performance and identify growth opportunities. Its AI technology is designed to automatically review claims, highlighting instances of over and underutilization to ensure appropriate care at reduced costs. Overjet's FDA-cleared platform is the first objective standard for oral health decision-making, enabling dentists to detect pathologies accurately and communicate effectively with patients. Established in 2018, Overjet is headquartered in Allston, Massachusetts.

Athelas

Series B in 2021
Athelas, Inc. is a healthcare company based in Mountain View, California, that specializes in developing and manufacturing in-home blood analysis devices aimed at diagnosing infections, inflammations, and malignancies. Founded in 2002, Athelas has created a portable optical unit that analyzes blood samples from a single drop, providing diagnostic reports to monitor the immune system. The company's FDA-cleared device is designed to help chronically ill patients manage their health at home, offering additional monitoring for blood pressure, weight, glucose levels, and medication adherence. This technology enables patients to monitor their immunity and assists healthcare providers in the early detection of conditions such as leukemia and other inflammatory diseases. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

Cadence Solutions

Series A in 2021
Cadence is a pioneering health technology company helping the nation’s largest health systems deliver world-class care outside of the four walls of the hospital.

SonderMind

Series C in 2021
SonderMind is a digital health and telehealth company based in Denver, Colorado, that aims to enhance access to behavioral health services. Founded in 2014, it operates an online directory connecting individuals with independent professionals offering mental health, massage, acupuncture, and nutrition services. The platform simplifies the process of finding well-matched therapists, allowing consumers to quickly access trusted care while enabling therapists to concentrate on patient treatment without the burden of administrative tasks. SonderMind combines various software tools and an integrated provider network to deliver high-quality behavioral healthcare, serving consumers, employers, and health systems effectively. The company's mission is to make behavioral health services more accessible and utilized.

OM1

Series D in 2021
OM1, Inc. is a digital health company that specializes in developing a platform for healthcare organizations to measure and forecast patient outcomes. The platform is designed to assist hospitals, health systems, and other healthcare providers in meeting various patient reported and clinical outcomes requirements for value-based care programs. By leveraging advanced predictive and prescriptive analytics, OM1 aims to mitigate risks, lower costs, and enhance the understanding of treatment outcomes across the care continuum. The company's technology gathers and synthesizes clinical data to provide AI-driven insights, enabling healthcare organizations to analyze and utilize outcomes data effectively. Founded in 2014 and based in Boston, Massachusetts, OM1 was previously known as Better Outcomes Corporation.

Evvy

Seed Round in 2021
Evvy is a company focused on improving female health by offering at-home vaginal microbiome tests. These tests utilize metagenomic sequencing to analyze symptoms and identify risks associated with important health issues. By providing personalized reports, Evvy aims to empower women with insights about their bodies, thereby addressing the gender health gap and enhancing overall health outcomes for women.

Osana

Series A in 2021
Osana is a healthtech company that provides a patient-centric omnichannel platform designed to improve the efficiency of healthcare resources. The platform offers subscription-based primary care services, which include features such as patient portals and data analysis. Through these capabilities, Osana delivers a range of services, including clinical analysis, emergency ambulance services, and video consultations. This approach enables healthcare providers to enhance their operations and deliver superior experiences to their patients.

Sword Health

Series C in 2021
Sword Health is a digital health company focused on revolutionizing physical rehabilitation through its advanced artificial intelligence care platform. The company aims to alleviate pain for billions of people by providing a unique solution that combines the expertise of physical therapy professionals with an interactive AI experience. This platform enables patients to access customized rehabilitation exercises from their homes, allowing them to receive supervised care anytime and anywhere. Sword Health's approach not only enhances patient independence but also offers valuable data to clinical teams and decision-makers, ultimately improving clinical and cost-saving outcomes in the field of physical therapy.

Transcarent

Series B in 2021
Transcarent is a consumer-directed health and care platform designed for employees of self-insured employers and their families. The company utilizes a blend of software, technology, and data science to provide consumers with unbiased information and trusted guidance. By connecting users to a network of high-value healthcare providers and services, Transcarent aims to empower individuals to make informed choices and achieve better health outcomes while navigating the complexities of the healthcare system. This approach fosters transparency and cost-effective decision-making, addressing a wide range of healthcare challenges faced by consumers today.

MD Ally

Seed Round in 2021
MD Ally, Inc. is a company focused on enhancing telemedicine services, specifically within the realm of emergency medical services. Incorporated in 2020 and based in Philadelphia, Pennsylvania, the company has developed a triage solution that addresses non-emergency care gaps. Its platform streamlines access between public safety practitioners and healthcare providers, enabling the triage of non-life-threatening medical concerns through telehealth. This allows patients to receive virtual medical and behavioral healthcare, in-network follow-up care, alternative transportation, and social services without the need for costly emergency service dispatch. By integrating telemedicine into the emergency medical dispatch process, MD Ally aims to provide efficient and effective care solutions for both patients and EMS providers.

Sesame

Series B in 2021
Sesame, Inc., also known as SesameCare, is a New York-based company founded in 2018 that specializes in providing a platform for booking medical appointments and consultations. The company distinguishes itself by offering affordable healthcare options, enabling Americans to access quality medical services at significantly reduced prices compared to traditional providers. By utilizing an AI-enabled marketplace, Sesame eliminates the need for insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. Additionally, Sesame serves as the official telehealth partner of Costco, further enhancing its reach and service offerings in the healthcare sector.

Ophelia

Series A in 2021
Ophelia offers medication and support for quitting opioids. They are a diverse collection of hearts and minds - doctors, scientists, techies, and citizens - on a mission to offer the best of medicine without the baggage of rehab. They are driven by science, committed to privacy, and bound to the client's right to make their own choices. They believe in recommendations, not orders. It was founded in 2019 and is based in New York, New York.

Empathy

Seed Round in 2021
Empathy is a platform designed to assist families in navigating the complexities of loss. By integrating technology with human support, Empathy offers a digital companion application that empowers bereaved families. The application serves as a comprehensive support system, guiding users through the emotional, financial, legal, and logistical challenges that arise after the death of a loved one. Through its innovative approach, Empathy aims to alleviate some of the burdens faced by families during difficult times.

BrightInsight

Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies, focusing on the development and optimization of regulated drugs, devices, and software. Founded in 2017 and headquartered in San Jose, California, the company offers a global regulated platform that utilizes Internet of Things (IoT) technology. This platform facilitates the capture, transmission, and analysis of data from connected medical devices, combination products, and digital therapeutics. By adhering to rigorous security, privacy, and regulatory standards, BrightInsight enables its clients to enhance patient adherence and engagement, streamline their processes, and accelerate time to market while reducing implementation costs. With an additional office in Hägglingen, Switzerland, BrightInsight is positioned to support customers in navigating the complexities of the digital health landscape.

Triomics

Seed Round in 2021
Triomics is a generative AI-powered platform focused on enhancing the efficiency of clinical trials, particularly in the field of oncology. The company aims to accelerate trial enrollment and improve healthcare operations by addressing operational inefficiencies in data collection and patient recruitment. Leveraging its advanced AI technology, which is trained to understand health records and medical terminology, Triomics facilitates a more streamlined approach to clinical research. Its platform supports pharmaceutical companies and contract research organizations in conducting rapid and cost-effective trials, ultimately advancing oncology research and care.

Ro

Series D in 2021
Ro is a telehealth company established in New York City in 2017, specializing in digital health clinics that cater to both men's and women's health, as well as smoking cessation. It offers a patient-centric healthcare system that integrates primary care services, diagnostics, and pharmacy solutions. The platform facilitates direct communication between patients and physicians, providing an end-to-end healthcare experience that encompasses diagnosis, medication delivery, and ongoing care management. Ro's services include personalized treatment options for issues such as erectile dysfunction and smoking cessation, all designed to enhance accessibility and affordability without relying on insurance. The company operates a nationwide provider network, incorporates an in-home care API, and utilizes proprietary pharmacy distribution centers to streamline healthcare services for its users.

Ossium Health

Series B in 2021
Ossium Health, Inc. is engaged in the development and manufacturing of cell therapy products aimed at treating leukemia, other blood cancers, and tissue damage, as well as addressing radiation poisoning. The company offers a range of innovative therapies, including HPC, Marrow, which features HLA-matched bone marrow stem cells for hematopoietic reconstitution in blood cancer patients; Chimera, which enhances organ transplantation; and Chymalis, composed of mesenchymal stem cells that promote the healing of damaged bone and muscle tissue. Additionally, Ossium provides bone marrow cells for research purposes in oncology and immunology. Founded in 2016 and headquartered in San Francisco, California, Ossium Health focuses on improving health outcomes and longevity through advanced bioengineering techniques.

ixlayer

Series A in 2021
ixlayer is a prominent player in the health-tech sector, specializing in virtual health testing solutions for health systems, payors, biopharma, and health-focused organizations. Founded in 2018, the company provides a comprehensive platform that addresses the technical, security, regulatory, and user experience aspects of complex health testing. As the healthcare landscape increasingly embraces remote care, ixlayer enhances patient engagement and supports preventative health strategies through scalable virtual testing options. The platform can be integrated into existing patient engagement systems and portals, facilitating real-time health and wellness lab testing. ixlayer currently serves millions of patients and has successfully launched numerous testing programs for major organizations, health systems, and government entities.

Sprinter Health

Seed Round in 2021
Sprinter Health is an on-demand mobile health company that sends full-time nurses and phlebotomists (“Sprinters”) into the home.

Circulo

Series A in 2021
Circulo Health is a Medicaid insurance company of the future, providing tech-enabled care to the sickest and poorest populations. Circulo is based in Columbus, Ohio, the emerging insurtech capital of the U.S.

Plume Clinic

Series A in 2021
Plume is a health tech company for the transgender community. The company focuses on radically increasing access to care, medication, and products for the trans community, supporting a bold, authentic and healthy lifestyle. Its vision is to make gender-affirming care available to anyone until it transforms healthcare for every trans life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.